OtherArticle
Gemcitabine-induced activation of the checkpoint signaling pathways that affect tumor cell survival
Larry M Karnitz, Karen S Flatten, Jill M. Wagner, David Loegering, Jennifer S Hackbarth, Sonnet JH Arlander, Benjamin T Vroman, M Bijoy Thomas, Yong-Un Baek, Kevin M Hopkins, Howard B Lieberman, Junjie Chen, William A Cliby and Scott H Kaufmann
Molecular Pharmacology September 15, 2005, DOI: https://doi.org/10.1124/mol.105.012716
Larry M Karnitz
Karen S Flatten
Jill M. Wagner
David Loegering
Jennifer S Hackbarth
Sonnet JH Arlander
Benjamin T Vroman
M Bijoy Thomas
Yong-Un Baek
Kevin M Hopkins
Howard B Lieberman
Junjie Chen
William A Cliby
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
OtherArticle
Gemcitabine-induced activation of the checkpoint signaling pathways that affect tumor cell survival
Larry M Karnitz, Karen S Flatten, Jill M. Wagner, David Loegering, Jennifer S Hackbarth, Sonnet JH Arlander, Benjamin T Vroman, M Bijoy Thomas, Yong-Un Baek, Kevin M Hopkins, Howard B Lieberman, Junjie Chen, William A Cliby and Scott H Kaufmann
Molecular Pharmacology September 15, 2005, DOI: https://doi.org/10.1124/mol.105.012716
OtherArticle
Gemcitabine-induced activation of the checkpoint signaling pathways that affect tumor cell survival
Larry M Karnitz, Karen S Flatten, Jill M. Wagner, David Loegering, Jennifer S Hackbarth, Sonnet JH Arlander, Benjamin T Vroman, M Bijoy Thomas, Yong-Un Baek, Kevin M Hopkins, Howard B Lieberman, Junjie Chen, William A Cliby and Scott H Kaufmann
Molecular Pharmacology September 15, 2005, DOI: https://doi.org/10.1124/mol.105.012716
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement